rectal cancer stage iii
Showing 1 - 14 of 14
Rectal Cancer Stage III, Rectal Cancer Stage IV Trial in Beijing (procedure, drug, device, diagnostic test)
Not yet recruiting
- Rectal Cancer Stage III
- Rectal Cancer Stage IV
- Sentinel lymph node biopsy
- +5 more
-
Beijing, Beijing, ChinaNational Cancer Center
Apr 26, 2023
Using Artificial Intelligence to Predict Rectal Cancer Outcomes
Completed
- Rectal Cancer Stage III
- As training material for deep learning model.
- As materials for external validation for the buildup model.
-
Taichung, TaiwanTaichung Verterans General Hospital
Feb 9, 2023
Rectal Cancer Stage III Trial in Germany (Oxaliplatin, 85 mg/m2, 5FU; 2400 mg/m2, 5FU, 250 mg/m2)
Recruiting
- Rectal Cancer Stage III
- Oxaliplatin, 85 mg/m2
- +11 more
-
Esslingen, Baden-Wuerttemberg, Germany
- +75 more
Dec 13, 2022
Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Guangzhou (drug, radiation, procedure, other)
Recruiting
- Rectal Cancer
- +3 more
- Capecitabine, Oxaliplatin
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 19, 2022
Rectal Cancer, Adenocarcinoma, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Madrid (neoadjuvant treatment)
Completed
- Rectal Cancer, Adenocarcinoma
- +4 more
- neoadjuvant treatment
-
Madrid, SpainHospital La Princesa
Aug 8, 2022
Serum Adipokines in Predicting Response to Neoadjuvant Therapy
Recruiting
- Rectal Cancer Stage III
- serum adipokines
-
Istanbul, TurkeyIstanbul Training and Research Hospital
Aug 5, 2022
Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Brussels, Kortrijk, Namur (drug, radiation, procedure)
Active, not recruiting
- Rectal Cancer Stage II
- Rectal Cancer Stage III
- Nivolumab 10 MG/ML Intravenous Solution
- +3 more
-
Brussels, Belgium
- +3 more
Jul 11, 2022
Rectal Cancer Stage III Trial in Hangzhou (Neoadjuvant chemoradiotherapy based on irinotecan)
Recruiting
- Rectal Cancer Stage III
- Neoadjuvant chemoradiotherapy based on irinotecan
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Dec 7, 2021
Neoadjuvant Chemoradiotherapy for Rectal Cancer
Recruiting
- Rectal Cancer Stage II
- Rectal Cancer Stage III
- MRI
- blood routine test
-
Beijing, Beijing, ChinaPeking University third hospital
Jul 11, 2021
Rectal Tumors, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Germany (drug, radiation, procedure)
Active, not recruiting
- Rectal Neoplasms
- +2 more
- Induction Chemotherapy arm A
- +4 more
-
Erlangen, Bavaria, Germany
- +21 more
Jun 2, 2021
Rectal Cancer, Rectal Tumors, Rectal Cancer Stage II Trial in Germany (radiation, drug, other)
Recruiting
- Rectal Cancer
- +3 more
- Radiotherapy
- +2 more
-
Erlangen, Germany
- +3 more
Jun 6, 2018
Rectal Cancer Stage III Trial in Shanghai (FOLFOXIRI+Cetuximab regimen)
Active, not recruiting
- Rectal Cancer Stage III
- FOLFOXIRI+Cetuximab regimen
-
Shanghai, S, ChinaDepartment of Radiation Oncology,Renji Hospital affiliated to Me
Jan 2, 2018
Optimal Surgery and MRI Based Radiochemotherapy in Rectal
Completed
- Rectal Cancer Stage II
- Rectal Cancer Stage III
- total mesorectal excision / long course radiochemotherapy
- long course 5-FU bases radiochemotherapy
-
Mainz, GermanyUniversity Medicine Center Department of General and Abdomial Su
Oct 18, 2016